168 related articles for article (PubMed ID: 38102636)
1. Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study.
Tayyib NA; Ramaiah P; Alshahrani SH; Margiana R; Almalki SG; Kareem AK; Zabibah RS; Shbeer AM; Ali SHJ; Mustafa YF
BMC Endocr Disord; 2023 Dec; 23(1):275. PubMed ID: 38102636
[TBL] [Abstract][Full Text] [Related]
2. Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity.
Turki Jalil A; Alameri AA; Iqbal Doewes R; El-Sehrawy AA; Ahmad I; Ramaiah P; Kadhim MM; Kzar HH; Sivaraman R; Romero-Parra RM; Ansari MJ; Fakri Mustafa Y
Front Endocrinol (Lausanne); 2022; 13():966590. PubMed ID: 36531466
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor of advanced glycation end product as a biomarker in neurocognitive and neuropsychiatric disorders: A meta-analysis of controlled studies.
Nameni G; Jazayeri S; Fatahi S; Jamshidi S; Zaroudi M
Eur J Clin Invest; 2024 May; ():e14232. PubMed ID: 38700073
[TBL] [Abstract][Full Text] [Related]
5. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: the Northern Manhattan Study.
Hudson BI; Dong C; Gardener H; Elkind MS; Wright CB; Goldberg R; Sacco RL; Rundek T
Metabolism; 2014 Sep; 63(9):1125-30. PubMed ID: 25012910
[TBL] [Abstract][Full Text] [Related]
8. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
9. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
10. Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies.
Hajizadeh-Sharafabad F; Shojaei-Zarghani S; Sharifi-Zahabi E; Gerami F; Pashaei MR
Glycoconj J; 2024 Feb; 41(1):35-46. PubMed ID: 38498243
[TBL] [Abstract][Full Text] [Related]
11. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.
Garay-Sevilla ME; Torres-Graciano S; Villegas-Rodríguez ME; Rivera-Cisneros AE; Wrobel K; Uribarri J
Acta Paediatr; 2018 Dec; 107(12):2146-2151. PubMed ID: 29846968
[TBL] [Abstract][Full Text] [Related]
13. Soluble receptor for advanced glycation end products and lipid profile ratio as cardiovascular risk markers in children with obesity.
Flores-Ramírez AG; Ibarra-Reynoso LDR; Garay-Sevilla ME
Gac Med Mex; 2023; 159(1):10-16. PubMed ID: 36930549
[TBL] [Abstract][Full Text] [Related]
14. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
15. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women.
Dozio E; Briganti S; Delnevo A; Vianello E; Ermetici F; Secchi F; Sardanelli F; Morricone L; Malavazos AE; Corsi Romanelli MM
Eur J Nutr; 2017 Dec; 56(8):2557-2564. PubMed ID: 27522371
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
17. Screen Time and Body Mass Index Among Children and Adolescents: A Systematic Review and Meta-Analysis.
Wu Y; Amirfakhraei A; Ebrahimzadeh F; Jahangiry L; Abbasalizad-Farhangi M
Front Pediatr; 2022; 10():822108. PubMed ID: 35620148
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products (sRAGE) correlates with obesity-related parameters, and it is not easy to be modified by moderate caloric restriction in obese humans.
Kanikowska D; Kanikowska A; Swora-Cwynar E; Grzymisławski M; Sato M; Breborowicz A; Witowski J; Korybalska K
J Physiol Pharmacol; 2022 Aug; 73(4):. PubMed ID: 36696243
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
